111 Platelet Disorders Flashcards

1
Q

What is the treatment of ITP with severe thrombocytopenia without significant bleeding?

A

Prednisone

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Dynamic process in which platelets and blood vessel wall play key roles

A

Hemostasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

Major regulator of platelet production and where is it synthesized?

A

Thrombopoietin TPO which is synthesized in the liver

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Increased synthesis of platelet is associated with inflammation and what interluekin?

A

Interluekin 6

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What is the average lifespan of platelets?

A

7 to 10 days

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Large multimeric protein present in both plasma and extracellular matrix of the sub endothelial vessel wall which platelet adhere to

A

VWF

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

Signals platelet aggregation

A

Glycoprotein IIb/IIIa

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

Stabilized platelet plug and develops simultaneously as product of coagulation cascade

A

Fibrin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

Processes that leads to thrombocytopenia

A
  1. Decreased bone marrow production
  2. Sequestration in the spleen
  3. Increased platelet destruction
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

Key step in evaluating a patient with thrombocytopenia

A

Review the peripheral blood smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is pseudothrombocytopenia?

A

In vitro artifact resulting from platelet agglutination via antibodies form the calcium content in the blood collection
(EDTA anticoagulated blood)
Remedy: collect blood in sodium citrate (blue top tube) or heparin (green top tube)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Platelet count to maintain vascular integrity in the microcirculation

A

Platelet count of 5-10K

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

Pinpoint non blanching hemorrhages and are usually a sign of decreased platelet number and not platelet dysfunction

A

Petechaie

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Most common noniateogenic cause of thrombocytopenia

A

Viral and bacterial infection

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

Platelet count less than 150K. Hgb and WBC count abnormal. Whats the next step?

A

Bone marrow examination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

Platelet count less than 150K. Hgb and WBC count normal. Whats the next step?

A

Peripheral blood smear

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

Platelet count less than 150K. Hgb and WBC count normal. PBS show clumped platelets. What’s the next step?

A

Redraw in sodium citrate or heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

Platelet count less than 150K. Hgb and WBC count. PBS fragmented RBC. What’s the diagnosis?

A

Micrioangiopathic hemolytic anemia (DIC, TTP)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

Platelet count less than 150K. Hgb and WBC count normal. PBS normal RBC. Normal Platelets. What are the considerations?

A

Drug induced thrombocytopenia
Infection induced thrombocytopenia
Idiopathic immune thrombocytopenia
Congenital thrombocytopenia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
20
Q

What differentiates HIT from other drug induced thrombocytopenia

A
  1. In HIT, thrombocytopenia is not usually severe with nadir counts rarely less than 20K
  2. Hit is not associated with bleeding but with markedly increased risk for thrombosis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
21
Q

Pathophysiology of HIT

A

Antibody formation to heparin. Protein platelet factor 4 (PF4) attached to heparin to form a complex. The anti hepatrin/PF4 antibody activates platelets through the FcYRIIa receptor and also activates monocyte and endothelial cells

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
22
Q

True or false. HIT is more common in UFH than in LWH.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
23
Q

When do patient manifest HIT?

A

5-10 days after exposure to heparin

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
24
Q

4T in the diagnostic algorithm of HIT

A

Thrombocytopenia
Timing of drop of platelet count
Thrombosis such as localized skin reaction
Other cause if thrombocytopenia not evident

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
25
Q

How is HIT diagnosed? What laboratory tests are used for HIT?

A
HIT remains a clinical diagnosis
Test for HIT
ELISA with PF4/polyanion complex
IgG ELISA
Platelet activation assat (serotonin release)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
26
Q

Why is ELISA PF4/polyanion has low specificity in what population of patient?

A

Low specificity among patibes who undergone cardiopulmonary bypass surgery where 50% develop antibodies postoperatively

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
27
Q

Common complication of HIT

A

Thrombosis both arterial and venous

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
28
Q

Drugs effective in HIT thrombosis. How long should it ge given?

A

Direct thrombin inhibitors like argatroban, bivalirudin
Anti thrombin binding polysaccharides like fondaparinux
Then transitions to warfarin

Given a few days after platelet recovery for for 1 month

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
29
Q

Can you give warfarin immediately to HIT thrombosis?

A

No as aspirin may lead to venous gangrene due to Clotting activation and severely reduced level of protein C and S

30
Q

Acquired disorder in which there is immune mediated destruction of platelets and possibly inhibition of platelet release from megakaryocyte

A

Idiopathic thrombocytopenia purpura

31
Q

Autoimmune disease commonly associated with secondary ITP

A

SLE

32
Q

Infections commonly associated with ITP

A

HIV and hepatitis C

33
Q

Pathogen assosciated with ITP

A

H. Pylori

34
Q

Autoimmune hemolytic anemia with ITP

A

Evan’s syndrome

35
Q

Mechanism of action is production of limited hemolysis with antibody coated cells saturating the Fc receptors, inhibiting FC receptor function

A

Rh0D immune globulin

36
Q

Rare complication of Rh0D immune Globulin

A

Severe intrvascular hemolysis

37
Q

Treatment options for ITP

A
  1. Glucocorticoids: prednisone
  2. Rh0D immune Globulin
  3. IVIg
  4. TPO receptor agonist: romiplostim (SQ) and eltrombopag (oral)
38
Q

Common feature among inherited thrombocytopenia

A

Large platelets

39
Q

Group of disorders characterized by thrombocytopenia, micrioangiopathic hemolytic anemia evident by fragmented RBCs. Examples?

A

Thrombotic thrombocytopenic micrioangiopathies

Examples: TTP, hemolytic uremic syndrome

40
Q

Differentiate between DIC and thrombocytopenic micrioangiopathies

A

DIC: consumption of Clotting factors

TTP and HUS: normal PT and aPTT

41
Q

Other name of inherited TTP

A

Upshaw-Schulman syndrome

42
Q

Pathophysiology of TTP

A

Deficiency of metalloprotease ADAMTS13 which cleaves VWF

43
Q

Findings to support TTP?

A
Increased LDH
Increased Indirect bilirubin
Decreased haptolgobin
Increased Reticulocyte count
Negative antiglobulin tests
44
Q

Main stay treatment of TTP

A

Plasma exchange

45
Q

Syndrome characterized by acute renal failure, micrioangiopathic hemolytic anemia and thrombocytopenia. Often preceeded by an episode of diarrhea

A

Hemolytic Uremic Syndrome

46
Q

Most frequut etiologic serotype of HUs

A

E coli O157:H7

47
Q

Primary treatment of HUS

A

Supportive

48
Q

Humanized monoclonal antibody against C5 that blocks terminal complement and has efficacy in resolution of HUS

A

Eculizumab

49
Q

Causes of thrombocytosis

A
Iron deficiency
Inflammation
Cancer
Infection
Essential thrombocythemia
Rarely: 5q- Myelodysplastic process
50
Q

True or false. Thrombocytosis in response to acute or chronic inflammation is associated with increased thrombotic risk

A

False.

51
Q

Inherited disorder absence of platelet Gp Ib-IX-V receptor

A

Bernard Soulier

52
Q

Inherited disorder. Absence of platelet Gp IIb/IIIa receptor

A

Glanzmann thrombasthenia

53
Q

Classic autosomal dominant qualitative platelet disorder resulting from abnormalities of platelet granule formation

A

Platelet storage pool disorder

54
Q

Most common inherited disorders of platelet function prevent normal secretion of granule content

A

Secretion disorders

55
Q

Treament for inherited disorders of platelet dysfunction

A

Platelet transfusion
Tranexamic acid
Desmopressin/DDAVP

56
Q

Treament for inherited disorders of platelet dysfunction

A

Platelet transfusion
Tranexamic acid
Desmopressin/DDAVP

57
Q

Common cause of acquired platelet dysfunction

A

Medication: antiplatelet or penicillins

58
Q

What is the platelet dysfunction in Uremia?

A

Defective adhesion and activation
improved by dialysis or
increasing hematocrit by 27-32%
DDAVP

59
Q

Most common inherited bleeding disorder

A

Von willebrand disease

60
Q

What is the role of VWF

A
  1. Major adhesion molecule that tethers the platelet to the exposed subendothelium
  2. Binding protein for FVIII resulting in significant prolongation of the FVIII half life circulation
61
Q

Most common type of VWD

A

Type 1: parallel decrease in VWF protein, VWF function and FVII level

62
Q

Common manifestation of VWD in female

A

Menorrhagia

63
Q

Which blood type has decreased levels of VWF

A

Blood type O

64
Q

VWD variant where gene affecting binding of FVIII; also known as autosomal hemophilia

A

Type 2N

65
Q

VWD variant describes patient with virtually no VWF and FVIII levels less than 10%

A

Type 3

66
Q

VWD variant describes increased susceptibility to cleavage by ADAMTS13

A

Type 2A

67
Q

VWD variant describes increased spontaneous binding of VWF to platelets in circulation

A

Type 2B

68
Q

Aortic stenosis with GI bleeding; attributed to prescience of angiodysplasia of the GI tract

A

Heyde Syndrome

69
Q

Treatment of VWD

A

DDAVP: releases VWF and FVIII from the endothelial stores

70
Q

True or false. DDAVP has 2h peak activity when given intranasally compared to 30 mins if IV.

A

True

71
Q

Major side effect of DDAVP

A

Hyponatremia

72
Q

What the use of vitamin C

A

Synthesize hydroxy proline which is an essential constituent of collagen